Status:
COMPLETED
Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities
Lead Sponsor:
Turku University Hospital
Conditions:
Sleep Apnea
Eligibility:
FEMALE
42-77 years
Phase:
PHASE2
PHASE3
Brief Summary
The purposes of this study are to evaluate the degree and duration of medroxyprogesterone acetate effect as well as tolerability in postmenopausal women with nasal continuous positive airway pressure ...
Detailed Description
Sleep apnea is a common condition affecting both genders. It is affecting more often males than females but after menopause the prevalence of sleep apnea increases in females compared to premenopausal...
Eligibility Criteria
Inclusion
- postmenopausal female
- regular controls of CPAP treatment in pulmonary clinic and regular use of CPAP device
Exclusion
- severe or unstable chronic illnesses
- heavy current smoking (over 10 cigarettes per day)
- medication which effects on the central nervous system
- contraindications to progesterone therapy and current participation in any other clinical study
Key Trial Info
Start Date :
January 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2000
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT01472315
Start Date
January 1 2000
End Date
November 1 2000
Last Update
March 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sleep Research Unit, Department of Physiology, Turku University
Turku, Finland, 20520